PT3288578T - Composições para limpeza do cólon e o tratamento de distúrbios gastrointestinais - Google Patents

Composições para limpeza do cólon e o tratamento de distúrbios gastrointestinais

Info

Publication number
PT3288578T
PT3288578T PT167216092T PT16721609T PT3288578T PT 3288578 T PT3288578 T PT 3288578T PT 167216092 T PT167216092 T PT 167216092T PT 16721609 T PT16721609 T PT 16721609T PT 3288578 T PT3288578 T PT 3288578T
Authority
PT
Portugal
Prior art keywords
compositions
treatment
gastrointestinal disorders
colon cleansing
cleansing
Prior art date
Application number
PT167216092T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of PT3288578T publication Critical patent/PT3288578T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT167216092T 2015-05-01 2016-04-29 Composições para limpeza do cólon e o tratamento de distúrbios gastrointestinais PT3288578T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01

Publications (1)

Publication Number Publication Date
PT3288578T true PT3288578T (pt) 2023-03-28

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167216092T PT3288578T (pt) 2015-05-01 2016-04-29 Composições para limpeza do cólon e o tratamento de distúrbios gastrointestinais

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP4218789A3 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA2984437C (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료
SMT202200173T1 (it) 2016-06-01 2022-05-12 Athira Pharma Inc Composti
EP4436980A1 (en) * 2021-11-24 2024-10-02 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
MX2024006317A (es) * 2021-11-24 2024-06-19 Ironwood Pharmaceuticals Inc Proceso sintetico para la produccion de agonistas del receptor de guanilato ciclasa c (gcc) modificados.
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DE602004028678D1 (de) * 2003-01-28 2010-09-23 Ironwood Pharmaceuticals Inc Zusammensetzungen zur Behandlung von Magen-Darm-Störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2331561A4 (en) * 2008-09-03 2013-02-27 Xenome Ltd PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
WO2011103311A2 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
KR102034748B1 (ko) * 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
EP4424697A3 (en) * 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료

Also Published As

Publication number Publication date
RS64160B1 (sr) 2023-05-31
FI3288578T3 (fi) 2023-05-03
JP2025169325A (ja) 2025-11-12
HUE061954T2 (hu) 2023-09-28
DK3288578T3 (da) 2023-05-01
JP2022121734A (ja) 2022-08-19
SMT202300114T1 (it) 2023-05-12
WO2016178979A1 (en) 2016-11-10
HRP20230381T1 (hr) 2023-07-07
CA2984437C (en) 2025-11-18
LT3288578T (lt) 2023-04-25
US20180148476A1 (en) 2018-05-31
BR112017023539A2 (pt) 2018-08-14
EA201792401A1 (ru) 2018-05-31
KR20250042844A (ko) 2025-03-27
CN108040482B (zh) 2022-03-29
KR102783759B1 (ko) 2025-03-21
SI3288578T1 (sl) 2023-07-31
JP6930919B2 (ja) 2021-09-01
MA41985B1 (fr) 2023-04-28
JP2024015335A (ja) 2024-02-01
CN108040482A (zh) 2018-05-15
CA2984437A1 (en) 2016-11-10
ES2947591T3 (es) 2023-08-11
CA3172777A1 (en) 2016-11-10
EP3288578A1 (en) 2018-03-07
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
PL3288578T3 (pl) 2023-08-14
MX2022013283A (es) 2022-12-13
EP4218789A3 (en) 2023-09-27
KR20180005675A (ko) 2018-01-16
EP3288578B8 (en) 2023-03-29
US10618938B2 (en) 2020-04-14
EP4218789A2 (en) 2023-08-02
EP3288578B1 (en) 2023-03-15
CN114716514A (zh) 2022-07-08
MD3288578T2 (ro) 2023-08-31
US20240199697A1 (en) 2024-06-20
CY1126031T1 (el) 2023-11-15
JP2018519254A (ja) 2018-07-19
DK3288578T5 (da) 2024-10-07
JP2020203954A (ja) 2020-12-24

Similar Documents

Publication Publication Date Title
HUE064141T2 (hu) Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
IL247452A0 (en) Compounds for treatment of complement mediated disorders
IL246833A0 (en) New salts and their pharmaceutical preparations for the treatment of inflammatory disorders
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
PT3119397T (pt) Compostos heterocíclicos para utilização no tratamento de distúrbios mediados por pi3k-gama
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
IL262852A (en) Treatment of complement-mediated disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
PT3288578T (pt) Composições para limpeza do cólon e o tratamento de distúrbios gastrointestinais
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
IL263080B (en) Treatment of neurological disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
ITUA20161679A1 (it) Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi
PL3448382T3 (pl) Arimoklomol do leczenia zaburzeń powiązanych z glukocerebrozydazą
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
KR101583452B9 (ko) 위장질환 치료용 의약 조성물
DK3423081T3 (da) Sammensætninger til brug i behandlingen af neurologisk sygdom
IT201700006355A1 (it) Composizione per il trattamento dei disturbi gastrointestinali
GB201516418D0 (en) Treatment of acute inflammatory disorders
GB201516140D0 (en) Treatment of acute inflammatory disorders
GB201602784D0 (en) New treatment of CFTR-related disorders